chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: MMRV
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report was received from other health professional referring to an unknown number of unspecified patients. Information regarding the patients' pertinent medical history, and drug reactions or allergies were not provided. On an unknown date starting on or after 31-JUL-2017, an unknown number of unspecified patients were administered improperly stored doses of PROQUAD lot # M043306, exp. 24-APR-2018, M044718, exp 17-MAY-2018; lot N010115, exp 24-SEP-2018). Lot information not available for properly stored sterile diluent (MERCK) used to reconstitute improperly stored PROQUAD. No adverse effect reported. The doses were stored in a temperature of -14 degree Celsius to -10 degree Celsius for 2 hours. Data logger was involved. There was no previous temperature excursion reported. No additional information provided. This case is cross-referenced with 1708USA009551 (same reporter). Sender's Comments: US-009507513-1708USA009551.
Age: 59.0
Sex: F
Vaccine: PNC13
Symptoms: Musculoskeletal pain, Pain in extremity
Clinical narrative: This is a spontaneous report from Pfizer sponsored program Pfizer RXPathways, from a contactable consumer reporting for herself. A 59-year-old female patient received PREVNAR 13, via an unspecified route of administration on an unspecified date at single dose for immunisation. The patient medical history and concomitant medications were not reported. The patient experienced pain in the upper right arm and shoulder since the day of vaccination. The outcome of the events was unknown.
Sex: F
Vaccine: PNC13
Symptoms: Arthralgia, Erythema, Influenza like illness, Injection site swelling, Mobility decreased
Clinical narrative: This is a spontaneous report from a contactable physician. A 59-year-old Anglo female patient received PREVNAR 13, via an unspecified route of administration on 18Jul2016 at single dose for immunization. The reporter was unable to clarify if this was the patient's first dose. The patient's medical history and concomitant medications were not reported. The patient previously received the Pneumococcal 23 in 2014, Lot number: K007824. The patient experienced flu type stuff, redness was 6 centimeters, still experiencing intermittent pain in shoulder, joint pain everywhere where she can't move, still has some weird symptoms going on an unspecified date. The patient also experienced huge swelling at sight of injection in Jul2016. Reporter mentioned the patient's weird symptoms haven't gone away, unable to say was it tied to vaccine or not. Flu type stuff clarified as muscle ache and fatigue. As well as upper respiratory sort of stuff. Patient had reported to reporter on 20Jul2016 she had the reaction of swelling the size of baseball where injection was given. Reporter explained by the time he saw the patient most of the swelling had gone away she had redness. Reporter explained when he saw the patient the sight of injection was not as bulging. Joint pain everywhere where she can't move: reporter explained everything he was checking the patient for was negative. The outcome of the events, still has some weird symptoms going on, intermittent pain in shoulder, were not recovered. The outcome of the other events was unknown.
Sex: F
Vaccine: PNC13
Symptoms: Muscle fatigue, Musculoskeletal pain, Myalgia, Respiratory symptom
Clinical narrative: This is a spontaneous report from a contactable physician. A 59-year-old Anglo female patient received PREVNAR 13, via an unspecified route of administration on 18Jul2016 at single dose for immunization. The reporter was unable to clarify if this was the patient's first dose. The patient's medical history and concomitant medications were not reported. The patient previously received the Pneumococcal 23 in 2014, Lot number: K007824. The patient experienced flu type stuff, redness was 6 centimeters, still experiencing intermittent pain in shoulder, joint pain everywhere where she can't move, still has some weird symptoms going on an unspecified date. The patient also experienced huge swelling at sight of injection in Jul2016. Reporter mentioned the patient's weird symptoms haven't gone away, unable to say was it tied to vaccine or not. Flu type stuff clarified as muscle ache and fatigue. As well as upper respiratory sort of stuff. Patient had reported to reporter on 20Jul2016 she had the reaction of swelling the size of baseball where injection was given. Reporter explained by the time he saw the patient most of the swelling had gone away she had redness. Reporter explained when he saw the patient the sight of injection was not as bulging. Joint pain everywhere where she can't move: reporter explained everything he was checking the patient for was negative. The outcome of the events, still has some weird symptoms going on, intermittent pain in shoulder, were not recovered. The outcome of the other events was unknown.
Age: 70.0
Sex: F
Vaccine: PNC13
Symptoms: Hypersensitivity, Injection site erythema, Injection site pruritus, Injection site warmth
Clinical narrative: This is a spontaneous report from a contactable pharmacist. A 70-year-old female patient received PREVNAR 13 (lot number: S31255, expiration date: Jul2018) intramuscular on arm left at the age of 70-year-old on 21Aug2017 at 0.5 ml, single for immunization. Patient medical history included high blood pressure and high cholesterol. Concomitant medications included atenolol and amlodipine both for high blood pressure; and simvastatin for high cholesterol, all from unspecified date and ongoing. The patient previously received PNEUMOVAX 23 for immunization. The pharmacist mentioned that patient was given PREVNAR 13 vaccination on 21Aug2017 (reported as several days ago) and patient had an allergic reaction to her arm on unspecified date. On 22Aug2017, patient experienced itchy, beet red, warm to the touch and it was not just only on the local site, down the arm to the elbow was also red, itchy, and warm to touch. Patient took some BENADRYL as treatment for the events. No lab work was done. Outcome of the events "it was not just only on the local site, down the arm to the elbow was also red, itchy, and warm to touch" was recovering, while "allergic reaction to her arm" was unknown. She said it actually had improved today but still itchy but not as bad as it was. Patient stated that the itching was what was driving her crazy. It was reported that itching has actually improved since she was here on the weekend. Pharmacist asked her if it was still warm to touch and patient said a little bit not like it was the day before. The reporter (pharmacist) provided causality for the events as related to the vaccine and mentioned "I would say yes, that's the only thing it could. I looked to see if there was bite on her arm, or she got bitten by something but I did not see anything."
Sex: U
Vaccine: MENB
Symptoms: Injection site erythema, Injection site pain, Musculoskeletal stiffness, Nausea
Clinical narrative: This is a spontaneous report from a contactable physician via a Pfizer sales representative. A patient of unspecified age, race/ethnicity and gender received TRUMENBA, intramuscular, on an unspecified date, at single dose, for immunisation. Relevant medical history and concomitant medications were not reported. The patient experienced pain and redness at the injection site, stiffness in the neck and nausea all on unspecified date with outcome of unknown.
Sex: F
Vaccine: MENB
Symptoms: Injection site swelling
Clinical narrative: This is a spontaneous report from a contactable consumer reporting for herself. This female patient of an unspecified age, race and ethnicity received a single dose of TRUMENBA via an unspecified route of administration on 28Aug2017 for immunization. The patient medical history and concomitant medications were not reported. On an unspecified day in Aug2017 the patient experienced some swelling at the injection site which has resolved on an unspecified day in Aug2017.
Age: 3.0
Sex: F
Vaccine: HEPA
Symptoms: Cerebrovascular accident, Hemiparesis, Mobility decreased
Clinical narrative: Suffered a stroke, CVA, was hospitalized at Hospital. Studies done, no identifiable cause of stroke. She has sustained (R) sided weakness/decreased mobility.
Sex: U
Vaccine: VARCEL
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report was received from a medical assistant, concerning multiple unspecified patients of an unknown age and gender. The patients' medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On an unspecified date, the patients were vaccinated with improperly stored doses of VARIVAX with the following lot numbers and expiration dates: M033211/13-JUL-2018, M049126/15-DEC-2018; also the ones reported as M045205/11-NOV-2018 and N014366/09-MAY-2019 (strength, dose, route of administration or anatomical location were not provided) for prophylaxis; which was reconstituted with a properly store sterile diluent (manufacturer unknown). The storage temperatures were 47 to 77 degrees Fahrenheit (°F) (47 °F) for a time frame of 21 minutes and 6 to 14 degrees Fahrenheit (°F) (9°F) for 42 minutes. There was no previous temperature excursion. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same source. Lot numbers M045205 and N014366 has been verified to be valid lot numbers for varicella virus vaccine live (Oka/Merck). As of 25-AUG-2017, all telephone attempts to obtain follow-up information have been unsuccessful. Sender's Comments: US-009507513-1708USA013008: US-009507513-1708USA013009: US-009507513-1708USA013010: US-009507513-1708USA013011: US-009507513-1707USA005187: US-009507513-1708USA013013: US-009507513-1708USA013006: US-009507513-1708USA013005: US-009507513-1708USA013007.
Sex: U
Vaccine: VARZOS
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report was received from a medical assistant, concerning multiple unspecified patients of an unknown age and gender. The patients' medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On an unspecified date, the patients were vaccinated with improperly stored doses of ZOSTAVAX with lot number M041511 and expiration date on 08-JAN-2018 (strength, dose, route of administration or anatomical location were not provided) for prophylaxis; which was reconstituted with a properly store sterile diluent (manufacturer unknown). The storage temperatures were 47 to 77 degrees Fahrenheit (°F) (47 °F) for a time frame of 21 minutes and 6 to 14 degrees Fahrenheit (°F) (9°F) for 42 minutes. There was no previous temperature excursion. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same source. As of 25-AUG-2017, all telephone attempts to obtain follow-up information have been unsuccessful. Sender's Comments: US-009507513-1708USA013008: US-009507513-1708USA013009: US-009507513-1708USA013010: US-009507513-1708USA013011: US-009507513-1708USA013012: US-009507513-1707USA005187: US-009507513-1708USA013006: US-009507513-1708USA013005: US-009507513-1708USA013007.
Sex: U
Vaccine: VARCEL
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report as received from a other health professional refers to a patient of unknown age. On an unknown date the patient was vaccinated with improperly stored dose of VARIVAX lot # M005973, expiry date: 02-FEB-2018 for prophylaxis. Concomitant therapies included sterile diluent. The dose of VARIVAX was exposed to a temperature of 15 degree Fahrenheit (F) to 46 F for a time frame of 4 hours 35 minutes. There were no previous temperature excursions. The call was due to a Digital data logger. No adverse effects reported. No Product Quality Complaint (PQC) was involved.
Sex: U
Vaccine: HEPA
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report as received from a other refers to unspecified number of patients of unknown ages. On unknown dates, the patients were vaccinated with improperly stored doses of VAQTA for prophylaxis. No adverse event.; Sender's Comments: US-009507513-1708USA013504:Original Case : 1708USA013476 US-009507513-1708USA013505: Original Case: 1708USA013476 US-009507513-1708USA013503: Original Case : 1708USA013476.
Sex: F
Vaccine: MMR
Symptoms: Autism spectrum disorder
Clinical narrative: This spontaneous report was received from an employee at pharmaceutical company who came across an article on a social media news feed and refers to a female patient of unknown age. The article from News Network and was posted 29-MAY-2017. On an unspecified date, the patient was vaccinated with measles, mumps, and rubella (MMR) vaccine (manufacturer not specified). The article indicated that the governments conceded or the court ruled that vaccines had caused brain injury. In turn, this injury led to an autism spectrum disorder (ASD) diagnosis and MMR vaccine was the common denominator in this case. The outcome of the event was unknown. Causality was assessed as related. Upon internal review, autism spectrum disorder was considered medically significant. This is one of several reports from the same source. Additional information is not expected. Sender's Comments: US-009507513-1708USA012166.
Sex: M
Vaccine: MMR
Symptoms: Autism spectrum disorder
Clinical narrative: This spontaneous report was received from an employee at pharmaceutical company who came across an article on a social media news feed and refers to a male patient of unknown age. The article from News Network and was posted 29-MAY-2017. On an unspecified date, the patient was vaccinated with measles, mumps, and rubella (MMR) vaccine (manufacturer not specified). The article indicated that the governments conceded or the court ruled that vaccines had caused brain injury. In turn, this injury led to an autism spectrum disorder (ASD) diagnosis and MMR vaccine was the common denominator in this case. The outcome of the event was unknown. Causality was assessed as related. Upon internal review, autism spectrum disorder was considered medically significant. This is one of several reports from the same source. Additional information is not expected. Sender's Comments: US-009507513-1708USA012166.
Age: 21.0
Sex: F
Vaccine: ANTH
Symptoms: Papule, Pruritus
Clinical narrative: The day after receiving her second dose of anthrax vaccine, patient developed pruritic papules which began on the arm where she received the vaccine and then appeared on her other arm, both legs, her back, and abdomen.  Pruritic papules persisted and patient was examined 9 days later.
Age: 12.0
Sex: F
Vaccine: HPV9, MNQ
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site rash, Injection site warmth
Clinical narrative: Approximately three and a half inch red, hot to touch, raised rash on her left arm where her injection site was. Was itchy and painful, but improving. Started evening 24+ hours after vaccine administered.
Age: 42.0
Sex: F
Vaccine: HEP
Symptoms: Erythema, Pruritus, Rash
Clinical narrative: Had a rash outbreak on same arm 2 hour later.  Small red, itch, and bumpy. Patient was told to take benadryl.
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ
Symptoms: Dizziness, Injection site erythema, Injection site swelling, Nausea, Vomiting
Clinical narrative: Nausea, vomiting, dizziness, site of MENACTRA was swollen and reddened.
Age: 74.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site inflammation, Injection site warmth
Clinical narrative: 3 days after IM injection of PNEUMOVAX, pt called and came into to clinic due to complaints that her injection site was warm to touch and had a 3.5 x 3 inch redness to the injection site. Edges of inflammation marked and patient was provided prescription for Keflex 500mg po BID x 7 days which she will start if the swelling does not diminish or worsens. Patient was already receiving ciprofloxacin for UTI.
Age: 12.0
Sex: F
Vaccine: MNQ
Symptoms: Fall, Heart rate increased, Hyperhidrosis, Hypertension, Pallor
Clinical narrative: After the patient received the vaccine, she became pale,and started to fall to the floor. After the patient was lowered to the floor, she became diaphoretic, pale, and her B/P and pulse were high. She was then returned to the exam room and placed in the Trendelenberg position and monitored. After 15 minutes, pulse and B/P returned to normal and the patients color was normal. The patient stated she felt fine, and was walked to the car with her mother and staff present. In a follow up call 1.5 hours later, the patient stated she was feeling fine and had no further problems.
Age: 13.0
Sex: M
Vaccine: MMRV
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: MMRV given to 13 year old client.
Age: 11.0
Sex: F
Vaccine: HPV9
Symptoms: Dizziness, Somnolence, Vomiting
Clinical narrative: 2) HPV vaccine reaction After she received the first HPV vaccine she shortly thereafter had vomiting, felt very faint, and felt very sleepy. She slept for about 3 hours and remained sleepy for the next 24 hours. She is wondering if it is safe for her to get the second HPV vaccine.
Age: 23.0
Sex: F
Vaccine: HEP, MMR, VARCEL
Symptoms: Injection site discomfort, Injection site erythema, Injection site induration, Injection site oedema, Injection site swelling
Clinical narrative: Client reports on 8/29 at 9 am she noticed redness, discomfort  and swelling in R posterior arm. On 8/30 client came to public health at 3:30 PM to notify staff of reaction. I took her information of the event and assessed site where vaccination occurred- Right posterior arm- mild edema, erythema mild- measures 70 by 90 mm with a central area of moderate erythema which is firm on palpation. Site is warm to touch. Temperature 99.6. Client denies any SOB, no difficulty swallowing, breathing, no rapid heartbeat. Client worked today without any distress or difficulty. Client reports itching and discomfort of RPA today. She has taken no medications-she is  breastfeeding. I advised ice to site, increased fluids and advised f/u with medical care if fever or swelling, pain increases.  Recheck 8/31. Client is on no medications and is breastfeeding. On 8/31 at 1: 50 client returned for recheck of RPA. Edema minimal, mild erythema spread in distal pattern. Central area of moderate erythema, 3 cm size remains firm. Entire site warm to touch. T- 99. Due to spread of erythema and continued central firmness - advised client to followup with medical provider for evaluation. Client states she is going to  Acute Care today as she is not working today.
Age: 23.0
Sex: F
Vaccine: HEP, MMR, VARCEL
Symptoms: Injection site warmth
Clinical narrative: Client reports on 8/29 at 9 am she noticed redness, discomfort  and swelling in R posterior arm. On 8/30 client came to public health at 3:30 PM to notify staff of reaction. I took her information of the event and assessed site where vaccination occurred- Right posterior arm- mild edema, erythema mild- measures 70 by 90 mm with a central area of moderate erythema which is firm on palpation. Site is warm to touch. Temperature 99.6. Client denies any SOB, no difficulty swallowing, breathing, no rapid heartbeat. Client worked today without any distress or difficulty. Client reports itching and discomfort of RPA today. She has taken no medications-she is  breastfeeding. I advised ice to site, increased fluids and advised f/u with medical care if fever or swelling, pain increases.  Recheck 8/31. Client is on no medications and is breastfeeding. On 8/31 at 1: 50 client returned for recheck of RPA. Edema minimal, mild erythema spread in distal pattern. Central area of moderate erythema, 3 cm size remains firm. Entire site warm to touch. T- 99. Due to spread of erythema and continued central firmness - advised client to followup with medical provider for evaluation. Client states she is going to  Acute Care today as she is not working today.
Sex: U
Vaccine: HEPA
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report as received from a other health professional refers to a patient of unknown age. On an unknown date the patient was vaccinated with VAQTA for prophylaxis. On an unknown date the patient experienced incorrect product storage and no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage and no adverse event to be not related to VAQTA. Sender's Comments: US-009507513-1708USA013517: US-009507513-1708USA013519: US-009507513-1708USA013516: US-009507513-1708USA013518.
Sex: U
Vaccine: HIBV
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report as received from a other refers to unspecified number of patients of unknown ages. On unknown dates, the patients were vaccinated with improperly stored doses of PEDVAXHIB for prophylaxis. No adverse event. Sender's Comments: US-009507513-1708USA013504: Original Case: 1708USA013476; US-009507513-708USA013505: Original Case: 1708USA013476; US-009507513-1708USA013476: Original Case: 1708USA013476.
Sex: U
Vaccine: RV5
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report as received from a other refers to unspecified number of patients of unknown age. On unknown dates, the patients were vaccinated with improperly stored doses of ROTATEQ, oral for prophylaxis. No adverse event. Sender's Comments: US-009507513-1708USA013476: Original Case: 1708USA013476; US-009507513-1708USA013505: Original Case: 1708USA013476; US-009507513-1708USA013503: Original Case: 1708USA013476.
Sex: U
Vaccine: HEP
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report as received from a other refers to unspecified number of patients of unknown age. On unknown dates, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB for prophylaxis. No adverse event. Sender's Comments: US-009507513-1708USA013504:Original Case : 1708USA013476; US-009507513-1708USA013476:Original Case : 1708USA013476; US-009507513-1708USA013503:Original Case : 1708USA013476.
Sex: U
Vaccine: HPV9
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report as received from a other health professional refers to a patient of unknown age. On an unknown date the patient was vaccinated with GARDASIL 9 for prophylaxis. On an unknown date the patient experienced incorrect product storage and no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage and no adverse event to be not related to GARDASIL 9. Sender's Comments: US-009507513-1708USA013519: US-009507513-1708USA013518: US-009507513-1708USA013488: US-009507513-1708USA013517.
Sex: U
Vaccine: PPV
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report as received from a other health professional refers to a patient of unknown age. On an unknown date the patient was vaccinated with PNEUMOVAX 23 for prophylaxis. On an unknown date the patient experienced incorrect product storage and no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage and no adverse event to be not related to PNEUMOVAX 23. Sender's Comments: US-009507513-1708USA013519: US-009507513-1708USA013518: US-009507513-1708USA013516: US-009507513-1708USA013488.
Sex: U
Vaccine: VARZOS
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report as received from a other health professional refers to a patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX for prophylaxis. Concomitant therapies included sterile diluent (MERCK). On an unknown date the patient experienced incorrect product storage and no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage and no adverse event to be not related to ZOSTAVAX. Sender's Comments: US-009507513-1708USA013519: US-009507513-1708USA013488: US-009507513-1708USA013516: US-009507513-1708USA013517.
Sex: U
Vaccine: VARCEL
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report as received from a other health professional refers to a patient of unknown age. On an unknown date the patient was vaccinated with VARIVAX for prophylaxis. Concomitant therapies included sterile diluent (MERCK). On an unknown date the patient experienced incorrect product storage and no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage and no adverse event to be not related to VARIVAX. Sender's Comments: US-009507513-1708USA013488: US-009507513-1708USA013518: US-009507513-1708USA013516: US-009507513-1708USA013517.
Age: 26.0
Sex: F
Vaccine: HEPA
Symptoms: No adverse event, Underdose
Clinical narrative: A pediatric vaccine was given to a adult. No reaction occurred after the vaccine. Correct vaccine given due to needing coverage to go out of the country.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: Laboratory test, Seizure like phenomena
Clinical narrative: Parent called and child seemed to have seizure like activity upon driving home from appointment in our office after vaccinations. Advised to go to ER for evaluation.
Age: 70.0
Sex: F
Vaccine: PPV
Symptoms: Blood potassium decreased, Drug administered at inappropriate site, Hypokalaemia, Leukocytosis, Mobility decreased
Clinical narrative: Patient developed severe arm pain 2 hours after injection. Unable to lift arm and went to ED for evaluation. Still symptomatic a week after when I saw her 8/30/17 in clinic and difficulty raising arm due to pain. Per patient, medical assistant gave vaccine "too high" (pointed to subacromial bursa) instead of usual deltoid space, so wonder if she inadvertently caused severe impingement symptoms with vaccine given in wrong location. Saw in clinic on 8/30/17 and provided subacromial corticosteroid injection with some relief.
Age: 70.0
Sex: F
Vaccine: PPV
Symptoms: Pain in extremity, White blood cell count increased, X-ray limb abnormal
Clinical narrative: Patient developed severe arm pain 2 hours after injection. Unable to lift arm and went to ED for evaluation. Still symptomatic a week after when I saw her 8/30/17 in clinic and difficulty raising arm due to pain. Per patient, medical assistant gave vaccine "too high" (pointed to subacromial bursa) instead of usual deltoid space, so wonder if she inadvertently caused severe impingement symptoms with vaccine given in wrong location. Saw in clinic on 8/30/17 and provided subacromial corticosteroid injection with some relief.
Age: 0.75
Sex: M
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site induration, Injection site warmth
Clinical narrative: About 24 hours after the vaccine, my son developed a hard and round circle the size of 3 quarters around the injection site. It was warm to touch. We were told it was a normal reaction but to draw a circle around it to ensure no spreading over next 12-24 hours or high fever. About 12 hours later the redness and warmth had gone done although it did spread about an inch or two. We teated with lavendar oil diluted in coconut oil 2x daily. It is slowly turning less red 48 hours later.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, FLU4, HEPA, MMRV
Symptoms: Extra dose administered
Clinical narrative: Patient came in with younger brother. Patient received brothers shots-Pediatric dose of FLUZONE & Hepatitis A. We (staff) checked with Dr. to make sure everything was okay. Dr. came in to talk with mother to let her know the extra dose of Hepatitis A will not harm her. She may continue to get the other pediatric dose of FLUZONE, in order for her to get the full dose. Mom was okay with this. Patient then received her kindergarten shots and another dose of FLUZONE (PROQUAD, QUADRACEL, pediatric FLUZONE).
Age: 1.08
Sex: M
Vaccine: DTAP, HIBV
Symptoms: Gianotti-Crosti syndrome, Herpes simplex test, Pyrexia, Rash, Rash generalised
Clinical narrative: Approximately 2 weeks after the vaccine was administered the child developed a raised rash on both arms. Over the next 2 weeks he developed a fever and a severe rash all over his body, which has been diagnosed either as Gianotti-Crosti Syndrome or Coxsackies A6. Parents applied cortisone cream with little to no help. He was taken to the doctor on 8/28/17, given both antibiotics and an antiviral and the areas were cultured.
Age: 1.08
Sex: M
Vaccine: DTAP, HIBV
Symptoms: Staphylococcus test, Varicella virus test
Clinical narrative: Approximately 2 weeks after the vaccine was administered the child developed a raised rash on both arms. Over the next 2 weeks he developed a fever and a severe rash all over his body, which has been diagnosed either as Gianotti-Crosti Syndrome or Coxsackies A6. Parents applied cortisone cream with little to no help. He was taken to the doctor on 8/28/17, given both antibiotics and an antiviral and the areas were cultured.
Age: 0.75
Sex: M
Vaccine: DTAP, UNK
Symptoms: Blood test, Crying, Dysstasia, Inability to crawl, Nuclear magnetic resonance imaging
Clinical narrative: Oone week after being vaccinated, the patient began to crawl awkwardly and cry when crawling, within a day the patient was unable to stand and was crying more often than usual. The evening he was taken to the ER, he was unable to stand or crawl and appeared to be in severe pain. it was determined that the patient had Toxic Synovitis in his hip.
Age: 0.75
Sex: M
Vaccine: DTAP, UNK
Symptoms: Pain, Synovitis, X-ray
Clinical narrative: Oone week after being vaccinated, the patient began to crawl awkwardly and cry when crawling, within a day the patient was unable to stand and was crying more often than usual. The evening he was taken to the ER, he was unable to stand or crawl and appeared to be in severe pain. it was determined that the patient had Toxic Synovitis in his hip.
Age: 65.0
Sex: M
Vaccine: FLU3
Symptoms: Asthenia, Body temperature increased, Chills, Dysphonia, Dyspnoea
Clinical narrative: On 08/28/2017 at approx. 04:30 PM my voice was becoming hoarse, it felt like there was something in my throat that need to be cleared. At around the same time my vision was getting blurred, I wiped my eyes and noticed that they were filled with something. I went to a bathroom window and saw that both eyes were filled with a yellow pussy discharge. I cleaned them out with water but the discharge built up almost immediately. By 6:30 PM I did not want to get out of my chair. My entire body was feeling weak. At that time I was overcome by chills, cold chills, so severe that I could not stop my entire body from shaking. August, 77 degrees inside. I wrapped myself in a comforter and after a short period began to feel warmer and the SEVERE shaking subsided. I also took my temperature: 100.6. At this point, approx. 6:45 PM while bundled up in my chair my breathing changed to GASPING and at the same time I could feel my heart beating Irregularly. I thought I was going into Cardiac Arrest. I was alone in the house and was too Freaked Out to call 911 although that is what was being recommended by all online sites regarding adverse reactions to flu shot. The gasping and irregular heartbeat seemed to go back to normal within 10 minutes or so. The eye discharge at this tome approx. 7:15PM had begun to improve. I was sitting still in my living room chair wrapped in a comforter until approx. 9:30 PM when I felt that I was going to survive the night and went to bed, still with chills but not nearly as bad as earlier. In the morning I felt somewhat weak, I hadn't eaten anything since the previous morning, had coffee and breakfast and as the day progressed I began to feel 100% again. This was my FIRST FLU SHOT, I will discuss this reaction with my Doctor when I have my annual exam next month.  Please feel free to contact me, via email preferred, if additional details needed.
Age: 65.0
Sex: M
Vaccine: FLU3
Symptoms: Eye discharge, Heart rate irregular, Purulent discharge, Throat irritation, Tremor
Clinical narrative: On 08/28/2017 at approx. 04:30 PM my voice was becoming hoarse, it felt like there was something in my throat that need to be cleared. At around the same time my vision was getting blurred, I wiped my eyes and noticed that they were filled with something. I went to a bathroom window and saw that both eyes were filled with a yellow pussy discharge. I cleaned them out with water but the discharge built up almost immediately. By 6:30 PM I did not want to get out of my chair. My entire body was feeling weak. At that time I was overcome by chills, cold chills, so severe that I could not stop my entire body from shaking. August, 77 degrees inside. I wrapped myself in a comforter and after a short period began to feel warmer and the SEVERE shaking subsided. I also took my temperature: 100.6. At this point, approx. 6:45 PM while bundled up in my chair my breathing changed to GASPING and at the same time I could feel my heart beating Irregularly. I thought I was going into Cardiac Arrest. I was alone in the house and was too Freaked Out to call 911 although that is what was being recommended by all online sites regarding adverse reactions to flu shot. The gasping and irregular heartbeat seemed to go back to normal within 10 minutes or so. The eye discharge at this tome approx. 7:15PM had begun to improve. I was sitting still in my living room chair wrapped in a comforter until approx. 9:30 PM when I felt that I was going to survive the night and went to bed, still with chills but not nearly as bad as earlier. In the morning I felt somewhat weak, I hadn't eaten anything since the previous morning, had coffee and breakfast and as the day progressed I began to feel 100% again. This was my FIRST FLU SHOT, I will discuss this reaction with my Doctor when I have my annual exam next month.  Please feel free to contact me, via email preferred, if additional details needed.
Age: 65.0
Sex: M
Vaccine: FLU3
Symptoms: Vision blurred
Clinical narrative: On 08/28/2017 at approx. 04:30 PM my voice was becoming hoarse, it felt like there was something in my throat that need to be cleared. At around the same time my vision was getting blurred, I wiped my eyes and noticed that they were filled with something. I went to a bathroom window and saw that both eyes were filled with a yellow pussy discharge. I cleaned them out with water but the discharge built up almost immediately. By 6:30 PM I did not want to get out of my chair. My entire body was feeling weak. At that time I was overcome by chills, cold chills, so severe that I could not stop my entire body from shaking. August, 77 degrees inside. I wrapped myself in a comforter and after a short period began to feel warmer and the SEVERE shaking subsided. I also took my temperature: 100.6. At this point, approx. 6:45 PM while bundled up in my chair my breathing changed to GASPING and at the same time I could feel my heart beating Irregularly. I thought I was going into Cardiac Arrest. I was alone in the house and was too Freaked Out to call 911 although that is what was being recommended by all online sites regarding adverse reactions to flu shot. The gasping and irregular heartbeat seemed to go back to normal within 10 minutes or so. The eye discharge at this tome approx. 7:15PM had begun to improve. I was sitting still in my living room chair wrapped in a comforter until approx. 9:30 PM when I felt that I was going to survive the night and went to bed, still with chills but not nearly as bad as earlier. In the morning I felt somewhat weak, I hadn't eaten anything since the previous morning, had coffee and breakfast and as the day progressed I began to feel 100% again. This was my FIRST FLU SHOT, I will discuss this reaction with my Doctor when I have my annual exam next month.  Please feel free to contact me, via email preferred, if additional details needed.
Age: 65.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Pruritic, red and swollen area of left upper arm.
Age: 48.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: 3 cm round and slightly raised erythematous, tender and warm over injection site. Treated with ibuprofen q4h with food and icing the area 3 x per day.
Age: 53.0
Sex: F
Vaccine: PPV
Symptoms: Arthralgia, Chills, Erythema, Headache, Malaise
Clinical narrative: Severe arm pain, 3 inch diameter redness and raised (day3). Fever, chills, malaise, arthralgia, skin tenderness, headache began day 2.
Age: 53.0
Sex: F
Vaccine: PPV
Symptoms: Pain in extremity, Pain of skin, Peripheral swelling, Pyrexia
Clinical narrative: Severe arm pain, 3 inch diameter redness and raised (day3). Fever, chills, malaise, arthralgia, skin tenderness, headache began day 2.
Age: 13.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Computerised tomogram normal, Eye movement disorder, Face injury, Fall, Haemorrhage
Clinical narrative: 13 year old male new to our clinic here with MGM for vaccines in MA visit. He received MCV4 and Tdap for an MA visit. After the MA visit, child was exiting room with MGM. He stopped in the hallway and suddenly fell forward, landing on his chin. He did not extend his arms to catch himself from the fall. The fall was witness by MA. After child fell, I was called from a room and came to child within a few seconds from the fall. When I arrived, he had been moved over to his back and was not responding. He was noted to be bleeding from a chin laceration that was approx 4 cm wide and deep enough to see the bone of the mandible. Pressure was applied to the bleeding. Child was tense and posturing for approx 5 seconds. He then regained consciousness and was not able to say where he was for approx 20 -30 seconds. A blood pressure cuff was placed on the right arm and BP was initially 83/52 with a HR in the 50's. O2 saturations were in the mid 90's. Within about 30 seconds, child was able to state his full name, state his location, and talk to his MGM. He was intermittently falling asleep with his eyes rolling back in his head. Given his LOC and significant laceration in addition to the mechanism of the fall, I opted to call EMS and have child transported to MC for further care and assessment. C-spine was held until EMS arrived. Repeat BP prior to EMS arrival was 96/63, HR in the 60's. O2 saturations in the mid 90's. He was placed on 0.5 L of mask O2 and pressure continued to be held on chin laceration. Upon arrival of EMS, child was alert and oriented, but sleepy. He did not want to open his mouth and complained of mouth and jaw pain. EMS sat child up and released him from C-spine. They recommended transport to MC in private vehicle; however, child's GM did not have a car and requested ambulance transport.
Age: 13.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Laceration, Loss of consciousness, Oral pain, Pain in jaw, Posturing
Clinical narrative: 13 year old male new to our clinic here with MGM for vaccines in MA visit. He received MCV4 and Tdap for an MA visit. After the MA visit, child was exiting room with MGM. He stopped in the hallway and suddenly fell forward, landing on his chin. He did not extend his arms to catch himself from the fall. The fall was witness by MA. After child fell, I was called from a room and came to child within a few seconds from the fall. When I arrived, he had been moved over to his back and was not responding. He was noted to be bleeding from a chin laceration that was approx 4 cm wide and deep enough to see the bone of the mandible. Pressure was applied to the bleeding. Child was tense and posturing for approx 5 seconds. He then regained consciousness and was not able to say where he was for approx 20 -30 seconds. A blood pressure cuff was placed on the right arm and BP was initially 83/52 with a HR in the 50's. O2 saturations were in the mid 90's. Within about 30 seconds, child was able to state his full name, state his location, and talk to his MGM. He was intermittently falling asleep with his eyes rolling back in his head. Given his LOC and significant laceration in addition to the mechanism of the fall, I opted to call EMS and have child transported to MC for further care and assessment. C-spine was held until EMS arrived. Repeat BP prior to EMS arrival was 96/63, HR in the 60's. O2 saturations in the mid 90's. He was placed on 0.5 L of mask O2 and pressure continued to be held on chin laceration. Upon arrival of EMS, child was alert and oriented, but sleepy. He did not want to open his mouth and complained of mouth and jaw pain. EMS sat child up and released him from C-spine. They recommended transport to MC in private vehicle; however, child's GM did not have a car and requested ambulance transport.
Age: 13.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Somnolence, Tension
Clinical narrative: 13 year old male new to our clinic here with MGM for vaccines in MA visit. He received MCV4 and Tdap for an MA visit. After the MA visit, child was exiting room with MGM. He stopped in the hallway and suddenly fell forward, landing on his chin. He did not extend his arms to catch himself from the fall. The fall was witness by MA. After child fell, I was called from a room and came to child within a few seconds from the fall. When I arrived, he had been moved over to his back and was not responding. He was noted to be bleeding from a chin laceration that was approx 4 cm wide and deep enough to see the bone of the mandible. Pressure was applied to the bleeding. Child was tense and posturing for approx 5 seconds. He then regained consciousness and was not able to say where he was for approx 20 -30 seconds. A blood pressure cuff was placed on the right arm and BP was initially 83/52 with a HR in the 50's. O2 saturations were in the mid 90's. Within about 30 seconds, child was able to state his full name, state his location, and talk to his MGM. He was intermittently falling asleep with his eyes rolling back in his head. Given his LOC and significant laceration in addition to the mechanism of the fall, I opted to call EMS and have child transported to MC for further care and assessment. C-spine was held until EMS arrived. Repeat BP prior to EMS arrival was 96/63, HR in the 60's. O2 saturations in the mid 90's. He was placed on 0.5 L of mask O2 and pressure continued to be held on chin laceration. Upon arrival of EMS, child was alert and oriented, but sleepy. He did not want to open his mouth and complained of mouth and jaw pain. EMS sat child up and released him from C-spine. They recommended transport to MC in private vehicle; however, child's GM did not have a car and requested ambulance transport.
Age: 65.0
Sex: F
Vaccine: FLU3, PNC13, TDAP
Symptoms: Burning sensation, Hypoaesthesia, Injection site pain
Clinical narrative: Patient experienced severe pain at injection site starting 1 day post immunization. She described a burning sensation that then started to travel to her left hand and down to her left foot. She says her left hand is numb and she can't feel her fingers. Patient sought medical attention on 8/9/17, 6 days after the immunization. She was prescribed MOBIC, FLEXERIL, NORCO. On 8/10 she received a topical steroid. On 8/11 she received an oral steroid and PERCOCET for the pain. She started taking NEURONTIN on 8/26 and says that is helping.
Age: 74.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Injection site pruritus, Injection site swelling, Injection site warmth, Rash erythematous
Clinical narrative: On 8/29, patient received FLUZONE HD and PNEUMOVAX IM injections into the left arm. Patient reports to pharmacy on 8/31 stating that he was experiencing itching and swelling at the injection site as well as a "warm" sensation. Patient followed up with urgent care, where he was treated empirically for a possible (SSTI) infection. Patient was prescribed KEFLEX 500mg three times daily for 7 days. Upon consultation, patient informed notifying pharmacist of event. Patient presented with minor erythematous rash along arm, however the swelling was delocalized and located near anterior portion of elbow. Patient did not complain of pain at this time, nor was site warm. Patient stated that he did not present to urgent care with elevated temperature or elevated blood pressure (documented at urgent care).
Age: 53.0
Sex: F
Vaccine: VARCEL
Symptoms: Asthenia, Dizziness, Fatigue, Feeling hot, Immediate post-injection reaction
Clinical narrative: Increased warmth, dizzy (lightheadedness), itchy, nausea immediately following first varicella immunization. No SOB nor chest pain, but felt tired and weak. This resulted in prolonged clinic visit for observation. Reaction resolved without any additional intervention.
Age: 53.0
Sex: F
Vaccine: VARCEL
Symptoms: Nausea, Pruritus
Clinical narrative: Increased warmth, dizzy (lightheadedness), itchy, nausea immediately following first varicella immunization. No SOB nor chest pain, but felt tired and weak. This resulted in prolonged clinic visit for observation. Reaction resolved without any additional intervention.
Age: 34.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Shot injected into Left tricep, area red, raised, hot to touch, measuring 8.5 x 7 cm. No treatment.
Age: 84.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Erythema, Peripheral swelling
Clinical narrative: Patient developed redness and slight swelling in the right arm (arm of PNEUMOVAX 23 injection) on 8/30/2017, which is one day after the vaccine. Today on 8/31/17 the reaction seems to be better and improving. Her left arm is ok with no signs of allergy or redness. Patient reported to MD and pharmacy. MD advised patient that it could be an allergic reaction to the PNEUMOVAX 23.
Age: 70.0
Sex: M
Vaccine: FLU3, PNC13
Symptoms: Arthralgia, Joint swelling, Pain in extremity, Peripheral swelling
Clinical narrative: Extreme pain and swelling in left hand, wrist, and elbow. Given IV morphine at ER then prescribed prednisone 50mg qd x 5 days and NORCO 7.5/325 q6h prn for pain.
Age: 84.0
Sex: M
Vaccine: PNC13
Symptoms: Injection site bruising, Pain in extremity, Vascular injury
Clinical narrative: Patient received a PREVNAR vaccine from our pharmacy and due to the administration of the vaccine the patient may have experienced a hit blood vessel. Per the patient report he had a extremely sore arm since getting the vaccine and was bruised from his elbow to shoulder on his right arm.
Age: 42.0
Sex: F
Vaccine: FLUC4
Symptoms: HIV test negative, Hepatitis B test negative, Hepatitis C test negative, Multiple use of single-use product
Clinical narrative: THE NEEDLE USED TO GIVE PATIENT HER FLU SHOT WAS USED ON ANOTHER PERSON. BOTH WAS SENT FOR LAB WORK (HIV, HEP B & C) CROSS CONTAMINATION. BOTH PATIENT LABS CAME BACK NEGATIVE.
Age: 52.0
Sex: F
Vaccine: FLU4
Symptoms: Erythema, Injected limb mobility decreased, Peripheral swelling
Clinical narrative: Swollen and red right arm to the elbow and she cannot move her arm, ice pack to bring swollen down.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Rash generalised, Rash pruritic
Clinical narrative: Patient has all over body rash, small raised bumps that itch. Symptoms occurred 1 day after vaccination. I recommend the patient use BENADRYL as well as hydrocortisone cream if needed. Also recommend the patient follow up with PCP to discuss this event. I counseled on signs/symptoms of serious allergic rxn and to go to ER if any trouble breathing occurs.
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Injection site erythema, Injection site warmth, Nausea, Oral mucosal blistering
Clinical narrative: Patient is experiencing marked swelling, with redness and heat at the injection site. Patient also has had nausea, blistering in the mouth and headache. Today she is feeling much better. Her Doctor's office suggested that she let us know about the reaction.
Age: 74.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Fatigue, Pruritus, Rash
Clinical narrative: PT STATED: RASH ON STOMACH, CHEST, LEFT INNER THIGH OF RIGHT LEG. PT STATED FEELING WEAK, TIRED, ITCHY.
Age: 54.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Injection site erythema, Injection site inflammation, Injection site pain, Pyrexia
Clinical narrative: Severe redness, inflammation, pain at injection site and fever. Patient took TYLENOL for pain and fever. Also ice the area.